Our Topical Application Manufacturing Services 

Topical formulations are applied directly to the skin, allowing for localized delivery of active ingredients. From formulation development to labeling, we enable comprehensive clinical-phase manufacturing for synthetic, biologic, and natural health products applied directly to the skin. Whether your product requires targeted delivery, enhanced stability or flexible packaging, our topical manufacturing services offer the expertise and scale to help you move confidently from lab to clinic. 

20211020 API 0734 (1)

Services Overview

cGMP Production

Full compliance with current Good Manufacturing Practices (cGMP) for topical applications at every stage of clinical manufacturing. 

Formulation Development & Prototyping

Synthetic and biologic formulations including solutions, lotions, creams, ointments, gels, pastes, aerosols, powders and solids. 

Stability Studies

Full product stability testing and support for shelf-life optimization. 

Packaging & Labelling

Flexible packaging formats including tubes, bottles, and blister packs; labelling up to 10,000 units/day. 

Licensing & Compliance

Health Canada Drug Establishment License, Health Canada Licenses for Restricted Substances, Health Canada Cannabis License and Health Canada License for Natural Health Products 

Did you find the service that meets your needs?

Start your journey with us.

Get In Touch

Contract Development Manufacturing Services & Facilities 

Clinical Trial Manufacturing

Our topical manufacturing services are delivered from the Katz Group Centre—an advanced facility that supports oral and topical dosage forms for clinical-phase production. With formulation and packaging flexibility, this site is ideal for dermatological, cosmetic and transdermal products. 

  • Manufacturing for topical dosage forms: creams, gels, ointments, and more

  • Throughput: Over 2,000 units/hour 

  • Small-scale batch capacity: up to 10 kg (small molecule APIs) 

  • Formulation prototyping for synthetic and biologic inputs 

  • Packaging formats: tubes, bottles (up to 2,000 x 50/100 mL), and blister packs 

  • Labelling capacity: up to 10,000 units/day 

  • Full stability study capabilities 

  • Suitable for Phase 1 & 2 clinical supply  

Meet Our Senior Leaders and Contacts

Allan Aginski
Member Highlight Hans Bauer
Shawn Couch
Vijay Somayaji

End-to-End Manufacturing Support

We provide comprehensive manufacturing solutions from preclinical stages to large-scale commercial production. Our integrated approach, combined with our Early Discovery & Development, Regulatory and Quantitative Solutions (QS) teams, ensures a seamless experience at every step of the development journey. 

Discover CRO Services
K&R 24 765 (1)